Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Peruvoside

Peruvoside is a potent inhibitor of Src, PI3K, JNK, STAT, and EGFR. Peruvoside induces apoptosis and autophagy and possesses a broad spectrum of anticancer activity in breast, lung, liver cancers and leukemia. Peruvoside is a broad-spectrum and potent antiviral activity against positive-sense RNA viruses. Peruvoside sensitizes Gefitinib -resistant tumour cells (A549, PC9/gef and H1975) to Gefitinib[1][2][3][4].

Product Specifications

CAS Number

1182-87-2

Product Name Alternative

Encordin

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Autophagy; EGFR; JNK; PI3K; Src; STAT

Type

Natural Products

Related Pathways

Apoptosis; Autophagy; JAK/STAT Signaling; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/peruvoside.html

Purity

99.32

Solubility

DMSO : ≥ 250 mg/mL

Smiles

O=C[C@@]([C@](C1)([H])CC2)(CC[C@@H]1O[C@H](O[C@H]3C)[C@H]([C@@H]([C@H]3O)OC)O)[C@](CC[C@@]45C)([H])[C@]2([H])[C@]4(CC[C@@H]5C(CO6)=CC6=O)O

Molecular Formula

C30H44O9

Molecular Weight

548.66

Precautions

H302, H315, H319, H335

References & Citations

[1]Lai Y, et al. Peruvoside is a novel Src inhibitor that suppresses NSCLC cell growth and motility by downregulating multiple Src-EGFR-related pathways. Am J Cancer Res. 2022 Jun 15;12 (6) :2576-2593.|[2]Reddy D, et al. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers. Life Sci. 2020 Jan 15;241:117147. doi: 10.1016/j.lfs.2019.117147. Epub 2019 Dec 9. PMID: 31830480.|[3]Feng Q, et al. Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death. Molecules. 2016 Apr 22;21 (4) :534.|[4]Wu KX, et al. The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses. Acta Pharm Sin B. 2023 May;13 (5) :2039-2055.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-01 0.02 mg (E-Coli)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details
Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-02 0.02 mg (Yeast)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details
Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-03 0.1 mg (E-Coli)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details
Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-04 0.1 mg (Yeast)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details
Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-05 0.02 mg (Baculovirus)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details
Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)
MBS1441297-06 0.02 mg (Mammalian-Cell)

Recombinant Rhodoferax ferrireducens Fructose-1,6-bisphosphatase class 1 2 (fbp2)

Sign In for Pricing
View Details